Second-Line Switch to Dolutegravir for Treatment of HIV Infection. Ombajo LA, Penner J, Nkuranga J, Mecha J, et al. N Engl J Med 2023;388:2349-2359.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ombajo LA, Penner J, Nkuranga J, Mecha J, et al. Second-Line Switch to Dolutegravir for Treatment of HIV Infection. N Engl J Med 2023;388:2349-2359.
PMID: 37342923